Speaker: Dr. Michael May, CEO of Rimon Therapeutics
Not that many years ago Michael May was finishing up his PhD thesis at the U of T. He is now the CEO of Rimon Therapeutics, a company he founded to commercialize his thesis work. Come and hear Michael talk about what it is like making the transition from the lab to the boardroom.
Click to find out more about the MaRS Entrepreneurship 101 Lecture Series.